OUR TEAM
We put our team behind our portfolio companies. Our deep experience in both science and business gives us a unique understanding of early-stage life science companies and the many challenges they may face.
BOARD OF DIRECTORS
-
Frank Epifano
Former CFO, Sanofi Pasteur
-
Jennifer Gilburg, MS
Deputy Secretary, Technology and Entrepreneurship
PA Department of Community and Economic Development -
Jon Morris, MD
Vice President, IQVIA
-
R. Sam Niedbala, PhD
CEO, CryoConcepts LP
-
Tom Penn, JD
Board Chair, Partner Emeritus, MVP Capital Partners
-
Stephanie Reisinger
Senior Vice President and General Manager, Real World Evidence, Flatiron Health (a Roche Subsidiary)
-
Alan Snyder, PhD
Former Vice President and Associate Provost for Research and Graduate Studies, Lehigh University
-
Rebecca Stametz, DEd, MPH
Vice President Digital Transformation, Geisinger Steele Institute for Health Innovation
-
Ronald P. Thiboutot, PhD
Former Executive V.P., Life Sciences Greenhouse Investments
-
Nishit Trivedi, PhD, MBBS
Director, Life Sciences, Emerald Advisers
-
Michele Washko MBA, MA
President and CEO, Life Sciences Greenhouse Investments
-
Haichen Yang, MD, MA, MBA
Vice President Clinical Research, Amicus Therapeutics
-
Vacant (Ex Officio)
Secretary, PA Department of Health
LSG STAFF
-
Michele Washko, M.B.A.
President & CEO
Michele Washko is President and CEO of LSG Investments. She brings to LSG nearly 25 years’ experience in healthcare commercialization, finance and innovation…
-
Greg Jackson, Ph.D.
Executive Vice President
Among Greg’s responsibilities are identification of new investment opportunities and conducting due diligence, as well as mentoring and monitoring performance of portfolio companies.
